Blackstone Inc’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,678,984
| Closed | -$235K | – | 205 |
|
|
2024
Q1 | $235K | Hold |
1,678,984
| – | – | ﹤0.01% | 166 |
|
|
2023
Q4 | $243K | Hold |
1,678,984
| – | – | ﹤0.01% | 151 |
|
|
2023
Q3 | $294K | Hold |
1,678,984
| – | – | ﹤0.01% | 144 |
|
|
2023
Q2 | $5.24M | Hold |
1,678,984
| – | – | 0.02% | 93 |
|
|
2023
Q1 | $4.3M | Hold |
1,678,984
| – | – | 0.02% | 101 |
|
|
2022
Q4 | $2.5M | Hold |
1,678,984
| – | – | 0.01% | 88 |
|
|
2022
Q3 | $2.92M | Hold |
1,678,984
| – | – | 0.01% | 93 |
|
|
2022
Q2 | $2.18M | Hold |
1,678,984
| – | – | 0.01% | 116 |
|
|
2022
Q1 | $4M | Hold |
1,678,984
| – | – | 0.01% | 138 |
|
|
2021
Q4 | $7.71M | Hold |
1,678,984
| – | – | 0.02% | 155 |
|
|
2021
Q3 | $13.6M | Hold |
1,678,984
| – | – | 0.03% | 128 |
|
|
2021
Q2 | $16.5M | Hold |
1,678,984
| – | – | 0.04% | 112 |
|
|
2021
Q1 | $14.8M | Hold |
1,678,984
| – | – | 0.03% | 107 |
|
|
2020
Q4 | $17.2M | Hold |
1,678,984
| – | – | 0.06% | 80 |
|
|
2020
Q3 | $15.2M | Hold |
1,678,984
| – | – | 0.06% | 78 |
|
|
2020
Q2 | $12M | Hold |
1,678,984
| – | – | 0.05% | 66 |
|
|
2020
Q1 | $15.9M | Hold |
1,678,984
| – | – | 0.12% | 37 |
|
|
2019
Q4 | $22.1M | Buy |
+1,678,984
| New | +$20.5M | 0.14% | 21 |
|
Other funds holding GRTX
Blackstone Inc's GRTX Position: Q2 2024 in Review
Blackstone Inc sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 1,678,984 shares — an estimated $235K sold.
Blackstone Inc first reported a position in GRTX in Q4 2019 and held it in 18 quarters. The position peaked at $22.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.
- Blackstone Inc reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Blackstone Inc sold 1,678,984 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $235K.
- Blackstone Inc first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 18 quarters.
- Blackstone Inc's Galera Therapeutics, Inc. Common Stock position peaked at $22.1M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.
Based on Blackstone Inc's 13F filing for Q2 2024, filed 14 Aug 2024.